Search

Your search keyword '"Alvisi P."' showing total 45 results
Start Over Author "Alvisi P." Journal digestive and liver disease
45 results on '"Alvisi P."'

1. PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN

Author

Catassi, G., primary, D'Arcangelo, G., additional, Norsa, L., additional, Bramuzzo, M., additional, Hojsak, I., additional, Kolho, K., additional, Romano, C., additional, Gasparetto, M., additional, Di Giorgio, A., additional, Hussey, S., additional, Yerushalmy-Feler, A., additional, Turner, D., additional, Matar, M., additional, Vais, B., additional, Karoliny, A., additional, Alvisi, P., additional, Tzivinikos, C., additional, and Aloi, M., additional

Published
2023
Full Text
View/download PDF

2. OC.04.5 DISEASE ACTIVITY PATTERNS IN THE FIRST 5 YEARS AFTER DIAGNOSIS IN CHILDREN WITH CROHN'S DISEASE: A POPULATION-BASED STUDY

Author

Distante, M., primary, Rotulo, S., additional, Ranalli, M., additional, Pedace, E., additional, Lionetti, P., additional, Arrigo, S., additional, Alvisi, P., additional, Miele, E., additional, Martinelli, M., additional, Zuin, G., additional, Bramuzzo, M., additional, Cananzi, M., additional, and Aloi, M., additional

Published
2023
Full Text
View/download PDF

4. T.06.7 INCIDENT COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE

Author

Neri, B., primary, Scribano, M.L., additional, Armuzzi, A., additional, Castiglione, F., additional, D’Incà, R., additional, Orlando, A., additional, Festa, S., additional, Riegler, G., additional, Fries, W., additional, Meucci, G., additional, Alvisi, P., additional, Mocciaro, F., additional, Papi, C., additional, Mossa, M., additional, Sena, G., additional, Guidi, L., additional, Testa, A., additional, Renna, S., additional, Frankovic, I., additional, Viola, A., additional, Patturelli, M., additional, Chiaramonte, C., additional, and Biancone, L., additional

Published
2022
Full Text
View/download PDF

5. P.07.10 PHYSICIANS' KNOWLEDGE AND APPLICATION OF IMMUNIZATION STRATEGIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SURVEY BY THE ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD)

Author

Macaluso, F.S., primary, Mazzola, G., additional, Ventimiglia, M., additional, Alvisi, P., additional, Renna, S., additional, Adamoli, L., additional, Galli, M., additional, Armuzzi, A., additional, Ardizzone, S., additional, Cascio, A., additional, Cottone, M., additional, and Orlando, A., additional

Published
2019
Full Text
View/download PDF

6. OC.09.6 PERFORATING CROHN'S DISEASE AND EXTENSIVE COLITIS AS RISK FACTORS FOR INCIDENT CANCER: A MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY AT 6 YEARS

Author

Petruzziello, C., primary, Armuzzi, A., additional, Scribano, M.L., additional, Castiglione, F., additional, D'Incà, R., additional, Daperno, M., additional, Papi, C., additional, Vecchi, M., additional, Fries, W., additional, Riegler, G., additional, Alvisi, P., additional, Mocciaro, F., additional, Testa, A., additional, Festa, S., additional, Neri, B., additional, Calabrese, E., additional, De Cristofaro, E., additional, Gesuale, C., additional, Di Mitri, R., additional, Spina, L., additional, Patturelli, M., additional, Rogai, F., additional, Renna, S., additional, Meucci, G., additional, Guidi, L., additional, Rossi, A., additional, Orlando, A., additional, and Biancone, L., additional

Published
2019
Full Text
View/download PDF

7. P065 Abdominal surgery for pediatric Crohn's disease patients: incidence, indications, complications and outcome

Author

Alvisi, P., primary, Romeo, E., additional, Bramuzzo, M., additional, Lionetti, P., additional, Illiceto, M.G., additional, Arrigo, S., additional, Romano, C., additional, Zuin, G., additional, Miele, E., additional, Gatti, S., additional, Aloi, M., additional, Caldaro, T., additional, Velkoski, A., additional, Renzo, S., additional, Faraci, S., additional, Pastore, M., additional, and Filardi, M.C., additional

Published
2018
Full Text
View/download PDF

8. P004 The current status of pediatric endoscopy in Italy: a national survey

Author

Deganello Saccomani, M., primary, Norsa, L., additional, Bramuzzo, M., additional, Gandullia, P., additional, Romano, C., additional, Miele, E., additional, Chiaro, A., additional, Francavilla, R., additional, Illiceto, M.T., additional, Paci, M., additional, Ravelli, A., additional, Bizzarri, B., additional, Balassone, V., additional, Muscas, A., additional, Campanozzi, A., additional, Alvisi, P., additional, Granata, A., additional, Costa, L., additional, Mandato, C., additional, Di Nardo, G., additional, Malamisura, B., additional, Motta, V., additional, Malaventura, C., additional, Fanti, L., additional, Centenari, C., additional, Dodaro, N., additional, Raffaele, A., additional, and Oliva, S., additional

Published
2018
Full Text
View/download PDF

10. P063 Pouchitis in pediatric ulcerative colitis: preliminary results of the retrospective multicenter study on behalf of the Italian Society for Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP)

Author

Dipasquale, V., primary, Mattioli, G., additional, Arrigo, S., additional, Bramuzzo, M., additional, Strisciuglio, C., additional, Faraci, S., additional, Romeo, E.F., additional, Zuin, G., additional, Felici, E., additional, Alvisi, P., additional, and Romano, C., additional

Published
2018
Full Text
View/download PDF

11. OC.12.3 INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

Author

Biancone, L., primary, Armuzzi, A., additional, Scribano, M.L., additional, Castiglione, F., additional, D'Incà, R., additional, Papi, C., additional, Spina, L., additional, Petruzziello, C., additional, Guidi, L., additional, Mocciaro, F., additional, Alvisi, P., additional, Ruffa, A., additional, Riegler, G., additional, Fries, W., additional, Daperno, M., additional, Renna, S., additional, Calabrese, E., additional, Di Mitri, R., additional, Vecchi, M., additional, Meucci, G., additional, Rogai, F., additional, Romeo, S., additional, Neri, B., additional, Festa, S., additional, Rossi, A., additional, Ardizzone, S., additional, Orlando, A., additional, and Pallone, F., additional

Published
2018
Full Text
View/download PDF

15. OC.11.1 INFLAMMATORY BOWEL DISEASE PHENOTYPE AS RISK FACTOR FOR CANCER IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

Author

Biancone, L., primary, Armuzzi, A., additional, Scribano, M.L., additional, D'Incà, R., additional, Castiglione, F., additional, Papi, C., additional, Angelucci, E., additional, Daperno, M., additional, Riegler, G., additional, Fries, W., additional, Meucci, G., additional, Alvisi, P., additional, Spina, L., additional, Ardizzone, S., additional, Petruzziello, C., additional, Mocciaro, F., additional, Ruffa, A., additional, Kohn, A., additional, Vecchi, M., additional, Guidi, L., additional, Di Mitri, R., additional, Renna, S., additional, Calabrese, E., additional, Rogai, F., additional, Rossi, A., additional, Orlando, A., additional, and Pallone, F., additional

Published
2016
Full Text
View/download PDF

17. Effect of early versus late azathioprine treatment in pediatric ulcerative colitis: Data from the Italian registry for pediatric IBD

Author

D’Arcangelo, G., primary, Bramuzzo, M., additional, Gasparetto, M., additional, Martinelli, M., additional, Alvisi, P., additional, Illiceto, M.T., additional, Valenti, S., additional, Pellegrino, S., additional, Catassi, C., additional, Arrigo, S., additional, Martelossi, S., additional, Cucchiara, S., additional, and Aloi, M., additional

Published
2015
Full Text
View/download PDF

18. OC.11.2 CHARACTERIZATION OF INCIDENT CASES OF CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS: A PROSPECTIVE MULTICENTER CASE-CONTROL IG-IBD STUDY

Author

Biancone, L., primary, Petruzziello, C., additional, Armuzzi, A., additional, Kohn, A., additional, D'Inca, R., additional, Papi, C., additional, Spina, L., additional, Guidi, L., additional, Scribano, M.L., additional, Calabrese, E., additional, Condino, G., additional, Onali, S., additional, Mocciaro, F., additional, Monterubbianesi, R., additional, Alvisi, P., additional, Fries, W., additional, Riegler, G., additional, Castiglione, F., additional, Frankovic, I., additional, Margagnoni, G., additional, Di Mitri, R., additional, Meucci, G., additional, Rogai, F., additional, Orlando, A., additional, Ardizzone, S., additional, and Pallone, F., additional

Published
2014
Full Text
View/download PDF

20. Validation of new ESPGHAN diagnostic criteria for celiac disease

Author

Proto, M., primary, Alvisi, P., additional, Barbera, C., additional, Campanozzi, A., additional, Cardile, S., additional, Romano, C., additional, Cozzali, R., additional, Castellucci, G., additional, Corvo, M., additional, Kleon, W., additional, Guariso, G., additional, Pescarin, M., additional, Kosova, P., additional, Malamisura, B., additional, Melli, P., additional, Parma, B., additional, Giancotti, L., additional, Pensabene, L., additional, Salvatore, S., additional, Tetro, A., additional, and Auricchio, R., additional

Published
2013
Full Text
View/download PDF

22. Natural history of potential celiac disease: Multicenter study

Author

Proto, M., primary, Alvisi, P., additional, Barbera, C., additional, Cardile, S., additional, Romano, C., additional, Cozzali, R., additional, Castellucci, G., additional, Colombo, C., additional, Guariso, G., additional, Pescarin, M., additional, Kosova, P., additional, Giancotti, L., additional, Pensabene, L., additional, D’Altilia, M.R., additional, and Auricchio, R., additional

Published
2013
Full Text
View/download PDF

23. P.02.9 INCIDENT CASES OF CANCER IN IBD: CLINICAL CHARACTERISTICS OF IBD VS IMMUNOMODULATORS IN A PROSPECTIVE MULTICENTER CASE-CONTROL STUDY

Author

Petruzziello, C., primary, Armuzzi, A., additional, Kohn, A., additional, D'Incà, R., additional, Papi, C., additional, Spina, L., additional, Guidi, L., additional, Scribano, M.L., additional, Onali, S., additional, Condino, G., additional, Calabrese, E., additional, Monterubbianesi, R., additional, Alvisi, P., additional, Fries, W., additional, Riegler, G., additional, Margagnoni, G., additional, Meucci, G.M., additional, Rogai, F., additional, Pallone, F., additional, and Biancone, L., additional

Published
2013
Full Text
View/download PDF

24. CO12 PHENOTYPE AND CLINICAL CHARACTERISTICS OF EARLY COMPARED TO LATE-ONSET PEDIATRIC INFLAMMATORY BOWEL DISEASE

Author

Aloi, M., primary, Lionetti, P., additional, Barabino, A., additional, Guariso, G., additional, Costa, S., additional, Fontana, M., additional, Romano, C., additional, Lombardi, G., additional, Staiano, A., additional, Alvisi, P., additional, Diaferia, P., additional, Baldi, M., additional, Romagnoli, V., additional, Gasparetto, M., additional, Di Paola, M., additional, Muraca, M., additional, Pellegrino, S., additional, Cucchiara, S., additional, and Martelossi, S., additional

Published
2012
Full Text
View/download PDF

25. PO56 SURVEY ON THE ASSESSMENT OF VITAMIN D STATUS IN PATIENTS WITH CHRONIC GASTROENTEROLOGIC DISEASE IN EMILIA ROMAGNA GASTROENTEROLOGIC PEDIATRIC CENTERS (ERPGC)

Author

Govoni, M.R., primary, Turlà, G., additional, Fabbri, E., additional, Malaventura, C., additional, Alvisi, P., additional, Lambertini, A., additional, Amarri, S., additional, Brusa, S., additional, Fornaro, R., additional, Pini, R., additional, Viola, L., additional, Zanacca, C., additional, Biasucci, G., additional, D'Amato, L., additional, and Alessandrini, S., additional

Published
2012
Full Text
View/download PDF

28. PP66 CELIAC DISEASE DIAGNOSIS IN EMILIA ROMAGNA REGION

Author

Brusa, S., primary, Marani, M., additional, Biasucci, G., additional, Amarri, S., additional, Di Biase, A.R., additional, Lambertini, A., additional, Malaventura, C., additional, Venturi, I., additional, Valenti, A., additional, Baldassarri, P., additional, Cecchini, I., additional, Viola, L., additional, and Alvisi, P., additional

Published
2011
Full Text
View/download PDF

32. PP63 PEDIATRIC GASTROENTEROLOGY: WHO DOES WHAT IN THE EMILIA ROMAGNA REGION

Author

Alvisi, P., primary, Marani, M., additional, Brusa, S., additional, Amarri, S., additional, Bizzarri, B., additional, Cecchini, I., additional, Denti, S., additional, Di Biase, A.R., additional, Fornaro, M., additional, Malaventura, C., additional, Pession, A., additional, Pini, R., additional, Venturi, I., additional, and Lambertini, A., additional

Published
2011
Full Text
View/download PDF

42. “Cervia Working Group Report”: Guidelines on the diagnosis and treatment of Helicobacter pyloriinfection

Author

Caselli, M., Parente, F., Palli, D., Covacci, A., Alvisi, V., Gasbarrini, G., and Bianchi Porro, G.

Abstract

Different national attitudes exist between countries in Europe concerning eradication of Helicobacter pyloriinfection due to the wide differences in Helicobacter pyloriprevalence, gastric cancer risk, bacterial resistance to antibiotics, health care systems and financial resources. The Cervia Working Group Report has been established in order to fill the gap in the absence of National Guidelines in Italy concerning the diagnosis and treatment of Helicobacter pyloriinfection. The recommendations made are, by and large, similar to the European Guidelines but differ slightly with regard to the “test-and-treat” approach to young dyspeptics without sinister symptoms. In the absence of a national validation of this strategy a case-by-case assessment of dyspepsia has been promoted, both at primary care and specialist level. Another area of partial disagreement concerns the eradication of Helicobacter pyloriin patients undergoing long-term proton pump inhibitor treatment which has not been generally recommended as scientific evidence in support of this policy is at present rather weak.

Published
2001
Full Text
View/download PDF

43. Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition

Author

Claudio Romano, Girolamo Mattioli, Giovanna Zuin, Patrizia Alvisi, Caterina Strisciuglio, Erminia Romeo, Matteo Bramuzzo, Valeria Dipasquale, Enrico Felici, Marco Ventimiglia, Anna Chiara Iolanda Contini, Serena Arrigo, Simona Faraci, Dipasquale, V., Mattioli, G., Arrigo, S., Bramuzzo, M., Strisciuglio, C., Faraci, S., Romeo, Ef., Contini, Ac., Ventimiglia, M., Zuin, G., Felici, E., Alvisi, P., and Romano, C.

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Chronic Active Colitis, medicine.medical_treatment, Kaplan-Meier Estimate, Pouchitis, Severity of Illness Index, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, Child, Pediatric gastroenterology, Aged, Proportional Hazards Models, Retrospective Studies, Colectomy, Hepatology, business.industry, Proctocolectomy, Ileal pouch anal anastomosis, Incidence, Proctocolectomy, Restorative, Hazard ratio, Ulcerative colitis, Gastroenterology, Retrospective cohort study, medicine.disease, Italy, 030220 oncology & carcinogenesis, Colitis, Ulcerative, Female, 030211 gastroenterology & hepatology, business
Abstract

Data on the epidemiology and risk factors for pouchitis following restorative proctocolectomy and ileal pouch-anal anastomosis (IPAA) in pediatric patients with ulcerative colitis (UC) are scarce.To determine incidence, risk factors and clinical outcome of pouchitis following IPAA in children.This multicenter, retrospective cohort study, included all pediatric UC patients who underwent colectomy and IPAA from January 2010 to December 2016.Eighty-five patients were enrolled. During a median post-surgical period of 24.8 (range: 1.0-72.0) months following IPAA, 38 (44.7%) patients developed pouchitis, including 6 (15.8%) who developed chronic pouchitis. Kaplan-Meier survival estimates of the cumulative probability for pouchitis were 14.6% at 1 year and 27.3% and 51.5% at 2 and 5 years, respectively. Multiple Cox regression model showed that older age at colectomy (hazard ratio, HR: 0.89, p = 0.008) was a protective factor, whereas chronic active colitis as indication for surgery (HR: 4.45, p 0.001), and a 3-stage IPAA (HR: 2.86, p = 0.028) increased the risk for pouchitis.Long-term risk for pouchitis is significantly high in pediatric-onset UC after IPAA. Younger age at colectomy, chronic active colitis as indication for surgery and 3-stage IPAA may increase the risk for pouchitis.

Published
2019
Full Text
View/download PDF

44. Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group

Author

Fortunata Civitelli, Matteo Bramuzzo, Claudia Banzato, Stefano Martelossi, Anna Dilillo, Maurizio Fuoti, Rosaria Celano, Caterina Strisciuglio, Claudio Romano, A. Marseglia, Sara Renzo, Massimo Martinelli, Simona Gatti, Lorenzo Norsa, Paolo Lionetti, Serena Arrigo, Erminia Romeo, P. Alvisi, Federica Mario, Enrico Felici, Daniela Knafelz, Roberto Panceri, Giulia D'Arcangelo, Valeria Dipasquale, Chiara Moretti, Arrigo, S., Alvisi, P., Banzato, C., Bramuzzo, M., Celano, R., Civitelli, F., D'Arcangelo, G., Dilillo, A., Dipasquale, V., Felici, E., Fuoti, M., Gatti, S., Knafelz, D., Lionetti, P., Mario, F., Marseglia, A., Martelossi, S., Moretti, C., Norsa, L., Panceri, R., Renzo, S., Romano, C., Romeo, E., Strisciuglio, C., and Martinelli, M.

Subjects
Male, Inflammatory bowel disease, Endoscopy, Gastrointestinal, lockdown, Immunosuppressive Agent, 0302 clinical medicine, Crohn Disease, Recurrence, Pandemic, Gastrointestinal Agent, Disease management (health), Child, immunosuppression, Alimentary Tract, Gastroenterology, Disease Management, Telemedicine, Hospitalization, Italy, Paediatric, 030220 oncology & carcinogenesis, Cohort, Biological Product, 030211 gastroenterology & hepatology, Electronic data, Female, Immunosuppressive Agents, Human, medicine.medical_specialty, Referral, Coronavirus disease 2019 (COVID-19), Adolescent, 03 medical and health sciences, Gastrointestinal Agents, medicine, Humans, Biological Products, Hepatology, business.industry, SARS-CoV-2, Inflammatory Bowel Disease, COVID-19, Paediatrics, medicine.disease, Inflammatory Bowel Diseases, digestive system diseases, Emergency medicine, Colitis, Ulcerative, business
Abstract

Background: IBD management has been significantly affected during the COVID-19 lockdown with potential clinical issues. Aims: The aim of this study was to analyse the impact of COVID-19 pandemic on the Italian paediatric IBD cohort. Methods: This was a multicentre, retrospective, cohort investigation including 21 different Italian IBD referral centres. An electronic data collection was performed among the participating centres including: clinical characteristics of IBD patients, number of COVID-19 cases and clinical outcomes, disease management during the lockdown and the previous 9 weeks. Results: 2291 children affected by IBD were enrolled. We experienced a significant reduction of the hospital admissions [604/2291 (26.3%) vs 1281/2291 (55.9%); p < 0.001]. More specifically, we observed a reduction of hospitalizations for new diagnosis (from n = 44 to n = 27) and endoscopic re-evaluations (from n = 46 to n = 8). Hospitalization for relapses and surgical procedures remained substantially unchanged. Biologic infusions did not significantly vary [393/2291 (17.1%) vs 368/2291 (16%); p = 0.3]. Telemedicine services for children with IBD were activated in 52.3% of the centres. In 42/2291(1.8%) children immunosuppressive therapies were adapted due to the concurrent COVID-19 pandemic. Conclusion: Due to the several limitations of the lockdown, cares for children with IBD have been kept to minimal standards, giving priorities to the urgencies and to biologics’ infusions and implementing telemedicine services.

Published
2021
Full Text
View/download PDF

45. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Author

Federica Mario, Federica Nuti, Chiara Moretti, Claudia Banzato, Lorenzo Norsa, Stefano Martelossi, Claudio Romano, Caterina Strisciuglio, Sara Renzo, Antonio Corsello, Maurizio Fuoti, Massimo Martinelli, Anna Dilillo, Zeno Giusti, Paolo Lionetti, Simona Gatti, Valeria Dipasquale, Fortunata Civitelli, Erminia Romeo, A. Marseglia, Enrico Felici, Matteo Bramuzzo, Roberto Panceri, Stefania Rampado, Serena Arrigo, Patrizia Alvisi, Daniela Knafelz, Giulia D'Arcangelo, Arrigo, Serena, Alvisi, Patrizia, Banzato, Claudia, Bramuzzo, Matteo, Civitelli, Fortunata, Corsello, Antonio, D'Arcangelo, Giulia, Dilillo, Anna, Dipasquale, Valeria, Felici, Enrico, Fuoti, Maurizio, Gatti, Simona, Giusti, Zeno, Knafelz, Daniela, Lionetti, Paolo, Mario, Federica, Marseglia, Antonio, Martelossi, Stefano, Moretti, Chiara, Norsa, Lorenzo, Nuti, Federica, Panceri, Roberto, Rampado, Stefania, Renzo, Sara, Romano, Claudio, Romeo, Erminia, Strisciuglio, Caterina, Martinelli, Massimo, Arrigo, S., Alvisi, P., Banzato, C., Bramuzzo, M., Civitelli, F., Corsello, A., D'Arcangelo, G., Dilillo, A., Dipasquale, V., Felici, E., Fuoti, M., Gatti, S., Giusti, Z., Knafelz, D., Lionetti, P., Mario, F., Marseglia, A., Martelossi, S., Moretti, C., Norsa, L., Nuti, F., Panceri, R., Rampado, S., Renzo, S., Romano, C., Romeo, E., Strisciuglio, C., and Martinelli, M.

Subjects
2019-20 coronavirus outbreak, medicine.medical_specialty, COVID-19, Inflammatory bowel disease, Paediatrics, SARS-CoV2, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Guidelines, Inflammatory bowel disease, Pediatrics, Disease course, 03 medical and health sciences, 0302 clinical medicine, Pandemic, Medicine, Humans, Intensive care medicine, Child, Hepatology, business.industry, SARS-CoV-2, Gastroenterology, Outbreak, COVID-19, Paediatrics, medicine.disease, Inflammatory Bowel Diseases, Organizational Innovation, Italy, Paediatric, 030220 oncology & carcinogenesis, Communicable Disease Control, Position paper, 030211 gastroenterology & hepatology, Risk Adjustment, business, Human
Abstract

Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results